- Cerebrovascular Events in Pediatric Inflammatory Bowel Disease: A Review of Published Cases
-
Rohani P, Taraghikhah N, Nasehi MM, Alimadadi H, Aghdaei HA
- KMID: 2529929
- Pediatr Gastroenterol Hepatol Nutr.
- 2022 May;25(3):180-193.
- doi: 10.5223/pghn.2022.25.3.180
Pediatric inflammatory bowel disease (PIBD) is a multisystem disorder characterized by intestinal and extraintestinal manifestations and complications. Cerebrovascular events (CVE) are rare extraintestinal complications in patients with PIBD. Statistics show... -
- CITED
-
- Close
- SHARE
-
- Close
- Medication Adherence in Korean Patients with Inflammatory Bowel Disease and Its Associated Factors
-
Oh K, Kwon EJ, Kim JH, Kim K, Lee JY, Hong HS, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Park JY, Park SH
- KMID: 2529434
- Ewha Med J.
- 2022 Apr;45(2):35-45.
- doi: 10.12771/emj.2022.45.2.35
Objectives: It is important that inflammatory bowel disease (IBD) patients adhere to their prescribed medication regimens to avoid the repeat exacerbations, complications, or surgeries associated with this disorder. However, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Functional Gastrointestinal Disorders in Patients with Inflammatory Bowel Disease
-
Kim KO
- KMID: 2525517
- Korean J Gastroenterol.
- 2022 Jan;79(1):4-11.
- doi: 10.4166/kjg.2022.001
With emerging more effective drugs, the therapeutic goal of inflammatory bowel disease (IBD) has progressed from clinical remission to mucosal healing. Although the inflammation could be controlled more effectively than... -
- CITED
-
- Close
- SHARE
-
- Close
- Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
-
Hong HS, Jung J, Park SH, Kim HJ, Hwang SW, Yang DH, Byeon JS, Myung SJ, Yang SK, Ye BD
- KMID: 2524243
- Korean J Intern Med.
- 2022 Jan;37(1):73-84.
- doi: 10.3904/kjim.2020.386
Background/Aims: Data on the immunoprotective status against measles, mumps, rubella, varicella zoster virus (VZV), hepatitis A virus (HAV), and Epstein-Barr virus (EBV) infection in patients with inflammatory bowel disease (IBD)... -
- CITED
-
- Close
- SHARE
-
- Close
- Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis
-
Lee YJ, Kim KO, Kim MC, Cho KB, Park KS, Jang BI, obotCaCAiDG(
- KMID: 2524765
- Gut Liver.
- 2022 Jan;16(1):81-91.
- doi: 10.5009/gnl210064
Background/Aims: This study aimed to investigate the perceptions and behaviors of patients with inflammatory bowel disease (IBD) during the early coronavirus disease 2019 (COVID-19) pandemic in the major epidemic area... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
-
Sakurai K, Furukawa S, Katsurada T, Otagiri S, Yamanashi K, Nagashima K, Onishi R, Yagisawa K, Nishimura H, Ito T, Maemoto A, Sakamoto N
- KMID: 2525075
- Intest Res.
- 2022 Jan;20(1):78-89.
- doi: 10.5217/ir.2020.00124
Background/Aims: Inflammatory bowel disease (IBD) patients frequently have zinc deficiency. IBD patients with zinc deficiency have higher risks of IBD-related hospitalization, complications, and requiring surgery. This study aimed to examine... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Multiple Bowen’s Disease in a Patient with Crohn’s Disease
-
Cho M, Lee JD, Cho SH, Woo YR, Kim HS
- KMID: 2524135
- Korean J Dermatol.
- 2021 Dec;59(10):793-796.
A 47-year-old man with a 25-year history of Crohn’s disease, presenting asymptomatic erythematous scaly patches (size, 1∼3 cm in diameter) on his back, left hand, right wrist, left ankle, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease A review
-
Chang JY, Cheon JH
- KMID: 2523520
- Precis Future Med.
- 2021 Dec;5(4):151-163.
- doi: 10.23838/pfm.2021.00128
The development of treatment options has revolutionized the prognosis of inflammatory bowel disease (IBD). However, a particular group of patients still experience therapeutic failure or drug side effects. Although the... -
- CITED
-
- Close
- SHARE
-
- Close
- Flattening in the Anteroposterior Direction of the Terminal Ileum or Sigmoid Colon Lying Across the Psoas Muscle on Magnetic Resonance Enterography in Patients with Crohn’s Disease
-
Kim DW, Park SH, Lee JS, Kim HJ, Kim AY, Ye BD, Yang SK
- KMID: 2520621
- Korean J Radiol.
- 2021 Oct;22(10):1640-1649.
- doi: 10.3348/kjr.2020.1420
Objective: Flattening in the anteroposterior direction (AP flattening) of the terminal ileum (TI) or sigmoid colon (SC) lying across the psoas muscle, on magnetic resonance enterography (MRE), might mimic bowel... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
-
Hisamatsu T, Suzuki Y, Kobayashi M, Hagiwara T, Kawaberi T, Ogata H, Matsui T, Watanabe M, Hibi T
- KMID: 2521604
- Intest Res.
- 2021 Oct;19(4):408-418.
- doi: 10.5217/ir.2020.00025
Background/Aims: Crohn’s disease is a chronic disorder; therefore, it is essential to investigate long-term safety and efficacy of treatments. This study assessed the safety and effectiveness of adalimumab for up... -
- CITED
-
- Close
- SHARE
-
- Close
- Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
-
Banerjee R, Pal P, Nabi Z, Shava U, Ganesh G, Reddy DN
- KMID: 2521603
- Intest Res.
- 2021 Oct;19(4):398-407.
- doi: 10.5217/ir.2020.00107
Background/Aims: Information on pediatric inflammatory bowel disease (PIBD) and very early onset IBD (VEOIBD) are sparse in India, where IBD is emerging. We aimed to evaluate characteristics of VEOIBD and... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of inflammatory bowel diseases: focusing on biologic agents and new therapies
-
Song HY, Seo GS
- KMID: 2520191
- J Korean Med Assoc.
- 2021 Sep;64(9):605-613.
- doi: 10.5124/jkma.2021.64.9.605
Background: The treatment of inflammatory bowel diseases has evolved with the development of anti-tumor necrosis factor agents. Despite the long-term effectiveness, many patients experience primary non-response, secondary loss of response,... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
-
Kim YS
- KMID: 2520190
- J Korean Med Assoc.
- 2021 Sep;64(9):596-604.
- doi: 10.5124/jkma.2021.64.9.596
Background: Recently, the incidence and prevalence rates of inflammatory bowel disease (IBD) have increased worldwide, including in Korea. Although there has been considerable progress in the management of IBD following... -
- CITED
-
- Close
- SHARE
-
- Close
- Intestinal microbiota and inflammatory bowel diseases
-
Eun CS
- KMID: 2520189
- J Korean Med Assoc.
- 2021 Sep;64(9):588-595.
- doi: 10.5124/jkma.2021.64.9.588
Background: The prevalence of inflammatory bowel diseases (IBD) has been rapidly increasing over the past several decades in Korea. IBD appears to be resulted from inappropriate and chronic activation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiology and diagnosis of inflammatory bowel diseases
-
Lee KM
- KMID: 2520188
- J Korean Med Assoc.
- 2021 Sep;64(9):579-587.
- doi: 10.5124/jkma.2021.64.9.579
Background: Over the past three decades, inflammatory bowel diseases (IBD) have been rapidly increasing in the African, South American, and Asian countries, including Korea. However, in Korea, the public awareness... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of inflammatory bowel diseases in Korea
-
Yang SK
- KMID: 2520187
- J Korean Med Assoc.
- 2021 Sep;64(9):572-577.
- doi: 10.5124/jkma.2021.64.9.572
Background: Inflammatory bowel disease (IBD) is a disease of unknown origin that causes chronic inflammation of the intestines and is classified as either ulcerative colitis or Crohn’s disease. The incidence... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in Nutrient Intake with Homemade versus Chef-Prepared Specific Carbohydrate Diet Therapy in Inflammatory Bowel Disease: Insights into Dietary Research
-
Morrison A, Braly K, Singh N, Suskind DL, Lee D
- KMID: 2520138
- Pediatr Gastroenterol Hepatol Nutr.
- 2021 Sep;24(5):432-442.
- doi: 10.5223/pghn.2021.24.5.432
Purpose: The aim of this study was to evaluate the nutrient content consumed by children and adolescents on home-prepared versus chef-prepared specific carbohydrate diets (SCD) as therapy for inflammatory bowel... -
- CITED
-
- Close
- SHARE
-
- Close
- Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
-
Park J, Park S, Lee SA, Park SJ, Cheon JH
- KMID: 2519779
- Korean J Intern Med.
- 2021 Sep;36(5):1040-1048.
- doi: 10.3904/kjim.2021.114
The incidence and prevalence rates of inf lammatory bowel disease (IBD) have been increasing in East Asian countries over the past few decades. Accordingly, the general understanding and awareness of... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study
-
Song JH, Kang EA, Park SK, Hong SN, Kim YS, Bang KB, Kim KO, Lee HS, Kang SB, Shin SY, Song EM, Im JP, Choi CH, Group of the Korean Association for the Study of Intestinal Diseases
- KMID: 2520127
- Gut Liver.
- 2021 Sep;15(5):752-762.
- doi: 10.5009/gnl20233
Background/Aims: Our study aimed to evaluate the long-term outcomes and risk factors for relapse after anti-tumor necrosis factor (TNF)-α cessation in inflammatory bowel disease (IBD) patients because they are not well... -
- CITED
-
- Close
- SHARE
-
- Close
- SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID
-
Lee YJ, Kim SE, Park YE, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, Lee JG, Yang HC, Choi M, Myung SJ, The Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases
- KMID: 2519380
- Korean J Gastroenterol.
- 2021 Aug;78(2):117-128.
- doi: 10.4166/kjg.2021.110
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, is threatening global health worldwide with unprecedented contagiousness and severity. The best strategy to overcome COVID-19 is a vaccine. Various vaccines... -
- CITED
-
- Close
- SHARE
-
- Close
